Selected research
Industry Research
Oxycodone Hydrochloride Analgesic Industry Research Report 2026
Market perspective
The global Oxycodone Hydrochloride Analgesic market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Oxycodone Hydrochloride Analgesic market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Oxycodone Hydrochloride Analgesic market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Oxycodone Hydrochloride Analgesic market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Oxycodone Hydrochloride Analgesic include Teva Pharmaceutical Industries Ltd, Mylan, Wellso Pharmaceutical, Purdue Pharma, NEPHARM, Napp Pharmaceuticals, Mallinckrodt, Epic Pharma, LLC and Amneal Pharmaceuticals, Inc.（Impax）. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Oxycodone Hydrochloride Analgesic market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Oxycodone Hydrochloride Analgesic.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oxycodone Hydrochloride Analgesic Market by Company
Teva Pharmaceutical Industries Ltd
Mylan
Wellso Pharmaceutical
Purdue Pharma
NEPHARM
Napp Pharmaceuticals
Mallinckrodt
Epic Pharma, LLC
Amneal Pharmaceuticals, Inc.（Impax）
Oxycodone Hydrochloride Analgesic Segment by Type
Tablets
Injections
Oxycodone Hydrochloride Analgesic Segment by Application
Hospital
Clinic
Others
Oxycodone Hydrochloride Analgesic Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Hydrochloride Analgesic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Hydrochloride Analgesic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Hydrochloride Analgesic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Oxycodone Hydrochloride Analgesic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Injections
Applications
- Hospital
- Clinic
- Others
Companies covered
- Teva Pharmaceutical Industries Ltd
- Mylan
- Wellso Pharmaceutical
- Purdue Pharma
- NEPHARM
- Napp Pharmaceuticals
- Mallinckrodt
- Epic Pharma, LLC
- Amneal Pharmaceuticals, Inc.（Impax）
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Oxycodone Hydrochloride Analgesic by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Tablets
- 2.2.3 Injections
- 2.3 Oxycodone Hydrochloride Analgesic by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Oxycodone Hydrochloride Analgesic Breakdown Data by Type
- 3.1 Global Oxycodone Hydrochloride Analgesic Historic Market Size by Type (2021-2026)
- 3.2 Global Oxycodone Hydrochloride Analgesic Forecasted Market Size by Type (2027-2032)
4 Oxycodone Hydrochloride Analgesic Breakdown Data by Application
- 4.1 Global Oxycodone Hydrochloride Analgesic Historic Market Size by Application (2021-2026)
- 4.2 Global Oxycodone Hydrochloride Analgesic Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Oxycodone Hydrochloride Analgesic Market Perspective (2021-2032)
- 5.2 Global Oxycodone Hydrochloride Analgesic Growth Trends by Region
- 5.2.1 Global Oxycodone Hydrochloride Analgesic Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Oxycodone Hydrochloride Analgesic Historic Market Size by Region (2021-2026)
- 5.2.3 Oxycodone Hydrochloride Analgesic Forecasted Market Size by Region (2027-2032)
- 5.3 Oxycodone Hydrochloride Analgesic Market Dynamics
- 5.3.1 Oxycodone Hydrochloride Analgesic Industry Trends
- 5.3.2 Oxycodone Hydrochloride Analgesic Market Drivers
- 5.3.3 Oxycodone Hydrochloride Analgesic Market Challenges
- 5.3.4 Oxycodone Hydrochloride Analgesic Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Oxycodone Hydrochloride Analgesic Players by Revenue
- 6.1.1 Global Top Oxycodone Hydrochloride Analgesic Players by Revenue (2021-2026)
- 6.1.2 Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Players (2021-2026)
- 6.2 Global Oxycodone Hydrochloride Analgesic Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Oxycodone Hydrochloride Analgesic Head Office and Area Served
- 6.4 Global Oxycodone Hydrochloride Analgesic Players, Product Type & Application
- 6.5 Global Oxycodone Hydrochloride Analgesic Manufacturers Established Date
- 6.6 Global Oxycodone Hydrochloride Analgesic Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Oxycodone Hydrochloride Analgesic Market Size (2021-2032)
- 7.2 North America Oxycodone Hydrochloride Analgesic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Oxycodone Hydrochloride Analgesic Market Size by Country (2021-2026)
- 7.4 North America Oxycodone Hydrochloride Analgesic Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Oxycodone Hydrochloride Analgesic Market Size (2021-2032)
- 8.2 Europe Oxycodone Hydrochloride Analgesic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Oxycodone Hydrochloride Analgesic Market Size by Country (2021-2026)
- 8.4 Europe Oxycodone Hydrochloride Analgesic Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Oxycodone Hydrochloride Analgesic Market Size (2021-2032)
- 9.2 Asia-Pacific Oxycodone Hydrochloride Analgesic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Oxycodone Hydrochloride Analgesic Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Oxycodone Hydrochloride Analgesic Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Oxycodone Hydrochloride Analgesic Market Size (2021-2032)
- 10.2 South America Oxycodone Hydrochloride Analgesic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Oxycodone Hydrochloride Analgesic Market Size by Country (2021-2026)
- 10.4 South America Oxycodone Hydrochloride Analgesic Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Oxycodone Hydrochloride Analgesic Market Size (2021-2032)
- 11.2 Middle East & Africa Oxycodone Hydrochloride Analgesic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Oxycodone Hydrochloride Analgesic Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Oxycodone Hydrochloride Analgesic Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Teva Pharmaceutical Industries Ltd
- 12.1.1 Teva Pharmaceutical Industries Ltd Company Information
- 12.1.2 Teva Pharmaceutical Industries Ltd Business Overview
- 12.1.3 Teva Pharmaceutical Industries Ltd Revenue in Oxycodone Hydrochloride Analgesic Business (2021-2026)
- 12.1.4 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Analgesic Product Portfolio
- 12.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
- 12.2 Mylan
- 12.2.1 Mylan Company Information
- 12.2.2 Mylan Business Overview
- 12.2.3 Mylan Revenue in Oxycodone Hydrochloride Analgesic Business (2021-2026)
- 12.2.4 Mylan Oxycodone Hydrochloride Analgesic Product Portfolio
- 12.2.5 Mylan Recent Developments
- 12.3 Wellso Pharmaceutical
- 12.3.1 Wellso Pharmaceutical Company Information
- 12.3.2 Wellso Pharmaceutical Business Overview
- 12.3.3 Wellso Pharmaceutical Revenue in Oxycodone Hydrochloride Analgesic Business (2021-2026)
- 12.3.4 Wellso Pharmaceutical Oxycodone Hydrochloride Analgesic Product Portfolio
- 12.3.5 Wellso Pharmaceutical Recent Developments
- 12.4 Purdue Pharma
- 12.4.1 Purdue Pharma Company Information
- 12.4.2 Purdue Pharma Business Overview
- 12.4.3 Purdue Pharma Revenue in Oxycodone Hydrochloride Analgesic Business (2021-2026)
- 12.4.4 Purdue Pharma Oxycodone Hydrochloride Analgesic Product Portfolio
- 12.4.5 Purdue Pharma Recent Developments
- 12.5 NEPHARM
- 12.5.1 NEPHARM Company Information
- 12.5.2 NEPHARM Business Overview
- 12.5.3 NEPHARM Revenue in Oxycodone Hydrochloride Analgesic Business (2021-2026)
- 12.5.4 NEPHARM Oxycodone Hydrochloride Analgesic Product Portfolio
- 12.5.5 NEPHARM Recent Developments
- 12.6 Napp Pharmaceuticals
- 12.6.1 Napp Pharmaceuticals Company Information
- 12.6.2 Napp Pharmaceuticals Business Overview
- 12.6.3 Napp Pharmaceuticals Revenue in Oxycodone Hydrochloride Analgesic Business (2021-2026)
- 12.6.4 Napp Pharmaceuticals Oxycodone Hydrochloride Analgesic Product Portfolio
- 12.6.5 Napp Pharmaceuticals Recent Developments
- 12.7 Mallinckrodt
- 12.7.1 Mallinckrodt Company Information
- 12.7.2 Mallinckrodt Business Overview
- 12.7.3 Mallinckrodt Revenue in Oxycodone Hydrochloride Analgesic Business (2021-2026)
- 12.7.4 Mallinckrodt Oxycodone Hydrochloride Analgesic Product Portfolio
- 12.7.5 Mallinckrodt Recent Developments
- 12.8 Epic Pharma, LLC
- 12.8.1 Epic Pharma, LLC Company Information
- 12.8.2 Epic Pharma, LLC Business Overview
- 12.8.3 Epic Pharma, LLC Revenue in Oxycodone Hydrochloride Analgesic Business (2021-2026)
- 12.8.4 Epic Pharma, LLC Oxycodone Hydrochloride Analgesic Product Portfolio
- 12.8.5 Epic Pharma, LLC Recent Developments
- 12.9 Amneal Pharmaceuticals, Inc.（Impax）
- 12.9.1 Amneal Pharmaceuticals, Inc.（Impax） Company Information
- 12.9.2 Amneal Pharmaceuticals, Inc.（Impax） Business Overview
- 12.9.3 Amneal Pharmaceuticals, Inc.（Impax） Revenue in Oxycodone Hydrochloride Analgesic Business (2021-2026)
- 12.9.4 Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Analgesic Product Portfolio
- 12.9.5 Amneal Pharmaceuticals, Inc.（Impax） Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst